# Cancer Center Support Grant

> **NIH NIH P30** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2020 · $150,000

## Abstract

VANDERBILT-INGRAM CANCER CENTER OVERALL
PROJECT SUMMARY/ABSTRACT
This is the fifth competing renewal of the Cancer Center Support Grant (CCSG) at Vanderbilt-Ingram Cancer
Center (VICC). VICC is a matrix center within Vanderbilt University Medical Center and Vanderbilt University
that integrates the cancer-related expertise and resources of the Schools of Medicine, Nursing, Arts and
Sciences and Engineering, the Peabody School of Education and the fully integrated Veterans Administration
Medical Center. The major clinical facilities and the majority of research facilities are located on one campus,
which promotes informal interactions, sharing of resources and productive collaborations. Established in 1993,
VICC functions as an organizational unit with a supra-departmental status. VICC-specific responsibilities and
aims are 1) to conduct, support and enhance state-of-the-art, multidisciplinary basic, clinical and population-
based research; 2) to coordinate and integrate cancer-related activities across Vanderbilt and to collaborate with
our local, regional, national and global partners; 3) to train and develop the next generation of cancer
investigators, cancer leaders and the continuum of cancer care providers; and 4) to assess and prioritize
community needs and to leverage partnerships to address those needs through cancer research, care and
control activities. The research, training, and community outreach and engagement objectives are accomplished
through CCSG and institutionally supported organizational capabilities, planning and evaluation, and eight
research programs. The VICC Research Programs are Signal Transduction and Cell Proliferation, Genome
Maintenance, Host-Tumor Interactions, Gastrointestinal Cancer, Translational Research and Interventional
Oncology, Breast Cancer, Cancer Epidemiology, and Cancer Health Outcomes and Control. Eleven shared
resources are proposed, all previously supported. Remarkable VICC growth and scientific discovery over the
past project period has led to 22 new multi-investigator grants for a total of 71, and 8 new training grants for a
total of 26. In addition, two NCI SPOREs were successfully renewed. With these and many other NCI grants,
peer-reviewed funding increased 35%. Significant accomplishments have been made in precision oncology,
cancer epidemiology, health outcomes and control, genomics, cancer drug discovery, early detection and
prevention, and cancer disparities research. Increased VICC space and facilities, along with philanthropic and
institutional funds, supported the recruitment of 67 new faculty, who join a dedicated team carrying out the VICC
mission: to alleviate cancer death and suffering through pioneering research; innovative patient-centered care;
and evidence-based prevention, education and community initiatives. VICC senior leadership provides effective
oversight and catalyzes innovative and paradigm-shifting science that translates to benefit for our patients and
the community we ...

## Key facts

- **NIH application ID:** 10245596
- **Project number:** 3P30CA068485-25S1
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** JENNIFER A PIETENPOL
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $150,000
- **Award type:** 3
- **Project period:** 1998-09-01 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10245596

## Citation

> US National Institutes of Health, RePORTER application 10245596, Cancer Center Support Grant (3P30CA068485-25S1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10245596. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*